ULTRA-LEVURE 100 mg, powder for oral suspension in a sachet 20 sachets
Brand page: Ultra-Levure (Saccharomyces boulardii) — all forms and strengths in France
Active ingredients: SACCHAROMYCES BOULARDII CNCM I-745
Commercialized according to BDPM
Powder for oral suspension20 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ULTRA-LEVURE 100 mg, poudre pour suspension buvable en sachet
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 20 sachet(s) papier aluminium polyéthylène
- Marketing authorisation holder
- BIOCODEX
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 16 Jan 2006
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69234258CIP73437944CIP133400934379444Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SACCHAROMYCES BOULARDII CNCM I-745poudre | 100,00 mg · un sachet de 306,00 mg | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.